Catalyst Pharmaceuticals Ownership | Who Owns Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals Ownership Summary
Catalyst Pharmaceuticals is owned by 80.07% institutional investors, 5.98% insiders, and 13.95% retail investors. Blackrock is the largest institutional shareholder, holding 16.01% of CPRX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.04% of its assets in Catalyst Pharmaceuticals shares.
CPRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Catalyst Pharmaceuticals | 80.07% | 5.98% | 13.95% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 18.69M | 16.01% | $289.58M |
| Deerfield management company, l.p. (series c) | 9.13M | 7.81% | $141.38M |
| Vanguard group | 8.10M | 6.93% | $125.47M |
| State street | 6.03M | 5.17% | $93.46M |
| Dimensional fund advisors lp | 3.00M | 2.57% | $46.48M |
| Pacer advisors | 2.97M | 2.54% | $45.97M |
| Geode capital management | 2.70M | 2.31% | $41.81M |
| First trust advisors lp | 2.47M | 2.12% | $38.31M |
| Renaissance | 2.18M | 1.86% | $33.70M |
| Janus henderson group | 2.18M | 1.86% | $33.70M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tanaka capital management | 153.39K | 5.62% | $2.38M |
| Gables capital management | 432.21K | 3.50% | $6.69M |
| Altium capital management lp | 500.00K | 3.16% | $7.75M |
| Jw asset management | 413.39K | 2.64% | $6.40M |
| Deerfield management company, l.p. (series c) | 9.13M | 2.35% | $141.38M |
| Opaleye management | 640.00K | 2.27% | $9.91M |
| Bridger management | 184.53K | 1.47% | $2.86M |
| Ikarian capital | 518.39K | 1.40% | $8.03M |
| Qsv equity investors | 84.14K | 1.36% | $1.30M |
| Knott david m jr | 212.00K | 1.31% | $3.28M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Pacer advisors | 2.97M | 0.10% | 2.97M |
| First trust advisors lp | 2.47M | 0.04% | 2.25M |
| Blackrock | 18.69M | 0.01% | 962.28K |
| Renaissance | 2.18M | 0.06% | 287.30K |
| Integral health asset management | 275.00K | 0.40% | 275.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 6.03M | 0.00% | -2.12M |
| Morgan stanley | 1.01M | 0.00% | -786.18K |
| Point72 asset management | - | - | -618.30K |
| Janus henderson group | 2.18M | 0.02% | -550.75K |
| Marshall wace, llp | 1.22M | 0.03% | -464.41K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Integral health asset management | 275.00K | 0.40% | 275.00K | $4.26M |
| Richard p slaughter associates | 162.20K | 0.59% | 162.20K | $2.51M |
| Qsv equity investors | 84.14K | 1.36% | 84.14K | $1.30M |
| Corebridge financial | 67.33K | 0.01% | 67.33K | $1.04M |
| Mirae asset global etfs | 63.93K | 0.00% | 63.93K | $987.12K |
Sold Out
| Holder | Change |
|---|---|
| Northwestern mutual wealth management | -3.00 |
| Aspire private capital | -20.00 |
| Financial gravity asset management | -21.00 |
| Newedge advisors | -70.00 |
| Innealta capital | -162.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 313 | 14.65% | 95,228,606 | -1.82% | 80 | 1.16% | 159 | 25.20% | 104 | 18.18% |
| Jun 30, 2024 | 270 | - | 96,978,188 | 0.88% | 83 | 1.02% | 126 | -20.75% | 87 | 26.09% |
| Mar 31, 2024 | 270 | 4.25% | 96,131,186 | 13.87% | 90 | 1.44% | 159 | 39.47% | 69 | -25.81% |
| Dec 31, 2023 | 259 | 1.17% | 84,423,146 | 4.08% | 79 | 1.36% | 114 | 1.79% | 93 | 3.33% |
| Sep 30, 2023 | 256 | 0.39% | 81,116,940 | -1.54% | 76 | 1.25% | 112 | -4.27% | 90 | 4.65% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 7.21M | 6.04% | 3.57K |
| Vanguard Total Stock Mkt Idx Inv | 3.53M | 2.96% | -19.80K |
| iShares Russell 2000 ETF | 3.10M | 2.60% | -6.47K |
| Pacer US Small Cap Cash Cows 100 ETF | 2.72M | 2.28% | -1.42K |
| First Trust NYSE Arca Biotech ETF | 1.93M | 1.62% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.66M | 1.40% | -6.08K |
| SPDR® S&P Biotech ETF | 1.34M | 1.13% | -40.77K |
| Fidelity Small Cap Index | 1.14M | 0.95% | -52.97K |
| iShares S&P Small-Cap 600 Growth ETF | 1.10M | 0.92% | - |
| SPDR® Portfolio S&P 600™ Sm Cap ETF | 1.02M | 0.85% | 752.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 10, 2024 | Miller Steve | Chief Op. & Scientific Officer | Sell | $1.10M |
| Nov 27, 2024 | INGENITO GARY | Chief Med. & Reg. Officer | Sell | $76.39K |
| Nov 27, 2024 | INGENITO GARY | Chief Med. & Reg. Officer | Sell | $196.27K |
| Nov 27, 2024 | Harper Molly | - | Sell | $385.00K |
| Nov 26, 2024 | Elsbernd Brian | Chief Compliance/Legal Officer | Sell | $85.36K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 14 |
| 2024 Q3 | - | 7 |
| 2024 Q2 | - | 5 |
| 2024 Q1 | - | 1 |
| 2023 Q4 | - | 9 |
CPRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools